8030411F24Rik Activators
Chemical activators of cystatin domain containing 1 can modulate the activity of this protein through a variety of biochemical pathways. Sodium orthovanadate acts as a phosphatase inhibitor, effectively maintaining proteins in their phosphorylated state. This action prevents the dephosphorylation of cystatin domain containing 1, thereby preserving its active form. Similarly, Calyculin A and Okadaic acid, both potent inhibitors of protein phosphatases 1 and 2A, ensure that cystatin domain containing 1 retains phosphorylation, a post-translational modification crucial for its activation. Forskolin, by elevating cyclic AMP levels, leads to the activation of protein kinase A (PKA), which can then phosphorylate and activate cystatin domain containing 1. Dibutyryl-cAMP, a cAMP analog, further reinforces this pathway by directly stimulating PKA, thereby promoting the phosphorylation and consequent activation of cystatin domain containing 1.
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which can then target cystatin domain containing 1 or associated proteins for phosphorylation, leading to activation. Ionomycin increases intracellular calcium levels, which can activate calcium-dependent kinases capable of phosphorylating cystatin domain containing 1. Anisomycin triggers stress-activated protein kinases, such as JNK and p38 MAP kinase, that may also target cystatin domain containing 1 for phosphorylation. Epidermal Growth Factor (EGF) stimulates its receptor, initiating a cascade involving the MAPK/ERK pathway, which has a multitude of targets, potentially including cystatin domain containing 1. Hydrogen peroxide, through oxidative stress mechanisms, activates a variety of signaling pathways that can lead to kinase activation and subsequent phosphorylation of cystatin domain containing 1. Lithium chloride inhibits GSK-3, indirectly affecting the Wnt signaling pathway, which may intersect with cystatin domain containing 1 activation pathways. Lastly, staurosporine, although generally a kinase inhibitor, can at low concentrations activate certain kinases that may phosphorylate and activate cystatin domain containing 1. Each of these chemicals, by influencing the phosphorylation state of cystatin domain containing 1 or its associated signaling proteins, can regulate the activity of this protein.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Sodium orthovanadate is a phosphatase inhibitor, known to enhance phosphorylation states of proteins. The activation of cystatin domain containing 1 could be mediated through enhanced phosphorylation, which can prevent dephosphorylation of proteins within signaling pathways that cystatin domain containing 1 is involved in, thereby promoting its activation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diacylglycerol analog that activates protein kinase C (PKC). PKC is known to phosphorylate a wide range of target proteins. By activating PKC, PMA could induce phosphorylation and subsequent activation of cystatin domain containing 1 or proteins that control its activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which can activate calcium-dependent protein kinases. These kinases could phosphorylate and activate cystatin domain containing 1 or proteins within its signaling network. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is an inhibitor of protein phosphatases 1 (PP1) and 2A (PP2A), which would prevent dephosphorylation of proteins. By inhibiting these phosphatases, calyculin A could maintain cystatin domain containing 1 in a phosphorylated and activated state. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Similar to calyculin A, okadaic acid is a potent inhibitor of PP1 and PP2A, leading to increased phosphorylation of proteins. This inhibition could result in the sustained activation of cystatin domain containing 1 through phosphorylation. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that also activates stress-activated protein kinases like JNK and p38 MAP kinase. Activation of these kinases could lead to phosphorylation and activation of cystatin domain containing 1 or its associated signaling proteins. | ||||||
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $31.00 $61.00 $95.00 | 28 | |
Hydrogen peroxide serves as a reactive oxygen species that can activate various signaling pathways through oxidative stress mechanisms. This can lead to the activation of kinases that may phosphorylate and activate cystatin domain containing 1. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cell-permeable analog of cAMP that can activate PKA. Upon PKA activation, it could phosphorylate and activate cystatin domain containing 1 or proteins within its regulatory network. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits glycogen synthase kinase-3 (GSK-3), which may lead to activation of the Wnt signaling pathway. Activation of Wnt signaling could potentially result in activation of cystatin domain containing 1 through downstream effects on signaling pathways. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a non-selective protein kinase inhibitor, but at low concentrations, it can act paradoxically to activate certain kinases. This could lead to activation of kinase signaling pathways that include cystatin domain containing 1 or its regulatory proteins. | ||||||